跳至主要内容
临床试验/CTRI/2017/11/010312
CTRI/2017/11/010312招募中4 期

Clinical evaluation of Sukumara Ghritam and Bramhi Churnam in the management of menopausal Syndrome - SBMS

CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • (1)Females of age between 40 and 55 years.
  • (2)Amenorrhoea for >= 12 months.
  • (3)Kupperman menopausal index score >= 15.
  • (4)FSH >= 20 IU/L.
  • (5)Thickness of endometrial <= 5 mm
  • (6)Willing and able to participate for 16 weeks

排除标准

  • (1)Patients with evidence of malignancy.
  • (2)Surgical menopause.
  • (3)Established cases of any mental illness.
  • (4)Patients with diabetes mellitus HbA1C > 6.5%
  • (5)Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, etc.)
  • (6) Any unstable cardio-vascular diseases.
  • (7) Patients with poorly controlled Hypertension (>= 160 /100 mm Hg)
  • (8)Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics,hormone replacement therapy etc. or any other drugs that may have an influence on the outcome of the study.
  • (9) Patients with concurrent hepatic disorder
  • (defined as Aspartate Amino Transferase (AST) and /or Alanine Amino Transferase (ALT) > 2 times
  • upper normal limit or Renal Disorders (defined as S. creatinine > upper limit of Lab.value),
  • Pulmonary Dysfunction (Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD])
  • (10)Alcoholics and/or drug abusers.
  • (11)H/o hypersensitivity to any of the trial drugs or their ingredients.
  • (12) Patients who have completed participation in any other Clinical trial during the past six (06) months.
  • (13) Any other condition which the Principal Investigator thinks may jeopardize the study.

研究者

相似试验

Treatment for Menopausal syndrome | 临床试验